Efficacy of Medical Therapy in Women and Men With Angina and Myocardial Bridging
Status:
Recruiting
Trial end date:
2025-06-15
Target enrollment:
Participant gender:
Summary
The proposed clinical trial is relevant to public health because it is expected to expand the
differential diagnosis and provide an evidence--based therapy for the large population of
patients with angina in the absence of obstructive CAD who currently remain undiagnosed and
untreated. It, therefore, upholds an important part of the mission of the The National Heart,
Lung, and Blood Institute (NHLBI), which is to promote the treatment of heart disease and
enhance the health of all individuals so that they can live longer and more fulfilling lives.